Article3D printing and additive manufacturing2025
3D-Printed Mycelium Biocomposites: Method for 3D Printing and Growing Fungi-Based Composites.
Article in 3D printing and additive manufacturing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Agro-mycelial derived biocomposite for circular economy: technological developments, strategic insights, and market dynamics.World journal of microbiology & biotechnology · 2026Review
- Recent advances in bioengineering and functional applications of microbial biocomposites: integrating bacterial cellulose, fungal mycelium and synthetic biology.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite recent advances in 3D printing and additive manufacturing, the main materials in rapid prototyping are derived from finite resources such as petroleum-based plastics. Researchers are developing alternatives to exhaustible and potentially environmentally harmful materials through biomaterials. Mycelium biocomposites are one promising area of inquiry; when mycelium decomposes biomass, it produces a composite biomaterial, which is fully compostable and has beneficial structural and hydrophobic properties. However, mold-based fabrication methods for biocomposites require tooling and limit the possible shapes. We introduce a novel method for directly 3D printing mycelium biocomposites without the need for molds or tooling. Our method comprises three main contributions: Mycofluid, a mycelium-inoculated paste that uses spent coffee grounds, a recycled biomass; Fungibot, a custom hardware system for 3D printing biopastes like Mycofluid; and a method for incubating mycelial growth within fresh 3D prints resulting in mycelium biocomposite parts. We illustrate our contributions through a series of objects showcasing our method and the material qualities of the parts. Notably, we demonstrate how living mycelium can fuse separate prints, enabling complex geometries that are otherwise challenging to 3D print as one part.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.